G2G CONSULTING

Lobbying for SHEPHERD THERAPEUTICS · rare cancer R&D

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · Massachusetts · House · Senate · posted Jan 20, 2026

Lobbying activity 4

Budget/Appropriations

regarding funding and awareness of rare cancers

Health Issues

regarding funding and awareness of rare cancers

Defense

regarding funding and awareness of rare cancers

Veterans

regarding funding and awareness of rare cancers

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.